These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 34343059)

  • 1. How can artificial intelligence be used for peptidomics?
    Perpetuo L; Klein J; Ferreira R; Guedes S; Amado F; Leite-Moreira A; Silva AMS; Thongboonkerd V; Vitorino R
    Expert Rev Proteomics; 2021 Jul; 18(7):527-556. PubMed ID: 34343059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine intelligence in peptide therapeutics: A next-generation tool for rapid disease screening.
    Basith S; Manavalan B; Hwan Shin T; Lee G
    Med Res Rev; 2020 Jul; 40(4):1276-1314. PubMed ID: 31922268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides.
    Goles M; Daza A; Cabas-Mora G; Sarmiento-Varón L; Sepúlveda-Yañez J; Anvari-Kazemabad H; Davari MD; Uribe-Paredes R; Olivera-Nappa Á; Navarrete MA; Medina-Ortiz D
    Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38856172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical assessment of AI in drug discovery.
    Walters WP; Barzilay R
    Expert Opin Drug Discov; 2021 Sep; 16(9):937-947. PubMed ID: 33870801
    [No Abstract]   [Full Text] [Related]  

  • 6. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
    Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
    Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial intelligence in drug discovery: recent advances and future perspectives.
    Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G
    Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
    [No Abstract]   [Full Text] [Related]  

  • 8. Machine Learning Advances in Predicting Peptide/Protein-Protein Interactions Based on Sequence Information for Lead Peptides Discovery.
    Ye J; Li A; Zheng H; Yang B; Lu Y
    Adv Biol (Weinh); 2023 Jun; 7(6):e2200232. PubMed ID: 36775876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empowering peptidomics: utilizing computational tools and approaches.
    Ferreira R; Amado F; Vitorino R
    Bioanalysis; 2023 Nov; 15(21):1315-1325. PubMed ID: 37737150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors.
    Shiammala PN; Duraimutharasan NKB; Vaseeharan B; Alothaim AS; Al-Malki ES; Snekaa B; Safi SZ; Singh SK; Velmurugan D; Selvaraj C
    Methods; 2023 Nov; 219():82-94. PubMed ID: 37778659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent applications of artificial intelligence in RNA-targeted small molecule drug discovery.
    Morishita EC; Nakamura S
    Expert Opin Drug Discov; 2024 Apr; 19(4):415-431. PubMed ID: 38321848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role and future prospects of artificial intelligence algorithms in peptide drug development.
    Chen Z; Wang R; Guo J; Wang X
    Biomed Pharmacother; 2024 Jun; 175():116709. PubMed ID: 38713945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.
    Gautam V; Gaurav A; Masand N; Lee VS; Patil VM
    Mol Divers; 2023 Apr; 27(2):959-985. PubMed ID: 35819579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on patient-specific facial and cranial implant design using Artificial Intelligence (AI) techniques.
    Memon AR; Li J; Egger J; Chen X
    Expert Rev Med Devices; 2021 Oct; 18(10):985-994. PubMed ID: 34404280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The machine learning life cycle and the cloud: implications for drug discovery.
    Spjuth O; Frid J; Hellander A
    Expert Opin Drug Discov; 2021 Sep; 16(9):1071-1079. PubMed ID: 34057379
    [No Abstract]   [Full Text] [Related]  

  • 16. Protein-DNA/RNA interactions: Machine intelligence tools and approaches in the era of artificial intelligence and big data.
    Cui F; Zhang Z; Cao C; Zou Q; Chen D; Su X
    Proteomics; 2022 Apr; 22(8):e2100197. PubMed ID: 35112474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Success stories of AI in drug discovery - where do things stand?
    Mak KK; Balijepalli MK; Pichika MR
    Expert Opin Drug Discov; 2022 Jan; 17(1):79-92. PubMed ID: 34553659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of artificial intelligence models and optimization algorithms in plant cell and tissue culture.
    Hesami M; Jones AMP
    Appl Microbiol Biotechnol; 2020 Nov; 104(22):9449-9485. PubMed ID: 32984921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Artificial Intelligence and Its Impact in Pharmaceutical Sciences: Insights Toward the Horizons Where Technology Meets Tradition.
    Bharadwaj S; Deepika K; Kumar A; Jaiswal S; Miglani S; Singh D; Fartyal P; Kumar R; Singh S; Singh MP; Gaidhane AM; Kumar B; Jha V
    Chem Biol Drug Des; 2024 Oct; 104(4):e14639. PubMed ID: 39396920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial intelligence for small molecule anticancer drug discovery.
    Duo L; Liu Y; Ren J; Tang B; Hirst JD
    Expert Opin Drug Discov; 2024 Aug; 19(8):933-948. PubMed ID: 39074493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.